Selenoprotein P status correlates to cancer-specific mortality in renal cancer patients
/in International Publications, Micronutrients /von 2012-10-09 / PLoS One 2012;7(10):e46644Dendritic cell-based tumor vaccinations in epithelial ovarian cancer: a systematic review
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2012-10-01 / Immunotherapy 2012 Oct;4(10):995-1009Dendritic cell-based immunotherapy in mesothelioma
/in Dendritic Cells, International Publications, Malignant Pleural Mesothelioma /von 2012-10-01 / Immunotherapy 2012 Oct;4(10):1011-22
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution